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Abstract
Background: The burden of preterm birth, fetal growth impairment, and associated neonatal deaths disproportionately falls on
low- and middle-income countries where modern obstetric tools are not available to date pregnancies and monitor fetal growth
accurately. The INTERGROWTH-21st gestational dating, fetal growth monitoring, and newborn size at birth standards make this
possible.
Objective: To scale up the INTERGROWTH-21st standards, it is essential to assess the feasibility and acceptability of their
implementation and their effect on clinical decision-making in a low-resource clinical setting.
Methods: This study protocol describes a pre-post, quasi-experimental implementation study of the standards at Jacaranda
Health, a maternity hospital in peri-urban Nairobi, Kenya. All women with viable fetuses receiving antenatal and delivery services,
their resulting newborns, and the clinicians caring for them from March 2016 to March 2018 are included. The study comprises
a 12-month preimplementation phase, a 12-month implementation phase, and a 5-month post-implementation phase to be completed
in August 2018. Quantitative clinical and qualitative data collected during the preimplementation and implementation phases
will be assessed. A clinician survey was administered eight months into the implementation phase, month 20 of the study.
Implementation outcomes include quantitative and qualitative analyses of feasibility, acceptability, adoption, appropriateness,
fidelity, and penetration of the standards. Clinical outcomes include appropriateness of referral and effect of the standards on
clinical care and decision-making. Descriptive analyses will be conducted, and comparisons will be made between pre- and
postimplementation outcomes. Qualitative data will be analyzed using thematic coding and compared across time. The study was
approved by the Amref Ethics and Scientific Review Committee (Kenya) and the Harvard University Institutional Review Board.
Study results will be shared with stakeholders through conferences, seminars, publications, and knowledge management platforms.
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Results: From October 2016 to February 2017, over 90% of all full-time Jacaranda clinicians (26/28) received at least one of
the three aspects of the INTERGROWTH-21st training: gestational dating ultrasound, fetal growth monitoring ultrasound, and
neonatal anthropometry standards. Following the training, implementation and evaluation of the standards in Jacaranda Health’s
clinical workflow will take place from March 2017 through March 5, 2018. Data analysis will be finalized, and results will be
shared by August 2018.
Conclusions: The findings of this study will have major implications on the national and global scale up of the
INTERGROWTH-21st standards and on the process of scaling up global standards in general, particularly in limited-resource
settings.
Registered Report Identifier: RR1-10.2196/10293
(JMIR Res Protoc 2018;7(6):e10293)  doi: 10.2196/10293
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Introduction
Background
The neonatal period (first 28 days of life) is the most vulnerable
time for an infant’s survival. In 2016, 2.6 million neonates died
globally representing 46% of all under-five deaths [1]. Most of
these deaths took place in low- and middle-income countries
(LMICs), including 80% in sub-Saharan Africa and South Asia
[1]. Preterm birth related complications are the primary cause
of neonatal deaths [1]. A common condition associated with
preterm birth is low birth weight (LBW; <2.5 kg), which
contributes to 60-80% of neonatal deaths [2] and can lead to
long-term complications, including developmental delays [2-7].
There are two causes of LBW in neonates: prematurity, growth
restriction during pregnancy resulting in a birthweight that is
small for gestational age (SGA) [8], or a combination of the
two conditions. SGA newborns have nearly twice the risk of
neonatal and post-neonatal mortality [3] and account for 21.9%
of neonatal deaths in LMICs [9].
To make sound clinical decisions and provide quality maternal
and neonatal care, clinicians require measurement standards for
accurate pregnancy dating, monitoring of fetal growth, and
assessment of newborn size and growth [8]. Such standards
enable clinicians to provide appropriately-timed antenatal care
(ANC) [10]; identify the need for high-risk ANC consultations
and referrals; and anticipate, identify, and manage fetal growth
restriction [10,11], preterm labor [12,13], and maternal and
neonatal [12] complications effectively [14]. The ability to date
a pregnancy accurately affects a clinician’s ability to make
informed decisions about appropriate timing of labor induction
for maternal and fetal indications (including prolonged gestation)
and elective or repeat caesarean sections [15]. Accurate
gestational dating is also essential for birth preparedness,
allowing women to plan for transportation to a birth facility at
the appropriate time [16]. Lastly, at the time of birth, correctly
assessing the neonate’s size for gestational age is critical for
appropriate clinical management and potential referral for
abnormal size and growth [17].
The date of the maternal last menstrual period (LMP) can be
used for pregnancy dating but is often inaccurate or unknown;
in these cases, ultrasound is the most accurate method for
determining gestational age [12,18-20]. Ultrasound is also the
gold standard for monitoring fetal growth disturbances [21].
However, ultrasound equipment is not always available and
fully functional in low-resource settings; even when it is, there
is often a lack of trained personnel with the technical knowledge
to use it effectively [22,23]. As a result, gestational age is often
not determined, which makes monitoring and intervention for
poor fetal growth impossible [22,23]. Because of this, the
standard for assessing gestational age and fetal growth in most
LMICs is date of LMP [12] and fundal height [24], respectively.
The literature has shown that both methods have a high margin
of error, which can lead to inaccurate dating, diagnoses, and
clinical management [25-27].
In 2014, the INTERGROWTH-21st Project completed a
five-year, global, prospective study of growth, health, nutrition,
and neurodevelopment. The study followed women and their
infants longitudinally from less than 14 weeks gestation until
two years postnatal. The project enrolled populations at low
risk of adverse outcome in Brazil, Italy, Oman, UK, USA,
China, India, and Kenya [28,29]. INTERGROWTH-21st data
were compiled to develop new prospective standards to be used
to assess pregnancy dating in the first trimester [30] and second
trimester [19], fetal growth [11] (including fundal height [24]
and ultrasound assessment [11]), and newborn size at birth
[13,17]. With these evidence- and globally-based standards, for
the first time, clinicians will be able to monitor growth based
on how healthy babies in any population should grow [14].
These standards complement the World Health Organization
(WHO) Child Growth Standards, together offering a
standardized method to assess growth throughout the continuum
of fetal life through early childhood development, which is
useful for both clinicians and patients.
To scale these standards and affect preterm birth and its
complications, including neonatal mortality, it is essential to
assess the feasibility and acceptability of implementing these
standards and their effect on clinical decision-making,
particularly in low-resource clinical settings.
Aim
We aim to assess the feasibility and acceptability of
implementing the INTERGROWTH-21st standards over a
one-year period at Jacaranda Health, a private, social enterprise
maternity hospital in peri-urban Nairobi, Kenya. To our
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knowledge, this is the first facility-based implementation study
of the INTERGROWTH-21st standards in a limited-resource
setting. The research design considers stakeholder inputs, the
physical and institutional environment, and the health system
structure.
The ultimate aim of the project is to use the results of the study
to inform the implementation and scale up of the
INTERGROWTH-21st standards in other settings and to inform
the translation of guidelines and tools into routine clinical
practice.
Primary Objective
The primary objective is to determine the facilitators and barriers
to implementing the INTERGROWTH-21st standards at
Jacaranda Health. The specific components of the primary
objective are to assess the introduction of the
INTERGROWTH-21st standards and the training of clinicians
at Jacaranda Health, the effect of the implementation of the
INTERGROWTH-21st standards on clinical practices at
Jacaranda Health, clinicians’ experiences and satisfaction with
the INTERGROWTH-21st standards, clinicians’ perceived effect
of the standards on the clinical care they provide, and patient
experiences and satisfaction with the care they received at
Jacaranda Health during implementation of the
INTERGROWTH-21st standards.
Secondary Objective
The secondary objective of this study is to assess the effect of
implementing the INTERGROWTH-21st standards on clinicians’
decision-making and patient outcomes, including the processes
for determining gestational age and estimated due date, internal
referral to Jacaranda Health clinicians providing high-risk
consultations, tertiary-center referral of high-risk pregnant
women, and indications for and rates of labor inductions and
caesarean sections.
Methods
Study Design
This is a pre-post, quasi-experimental implementation study
using quantitative clinical data, focus group discussions (FGDs),
in-depth interviews (IDIs), and a short clinician survey. The
study describes the feasibility, acceptability, and the effect of
implementing the INTERGROWTH-21st standards on clinical
decision-making and management at Jacaranda Health. Study
activities consisted of a 12-month preimplementation phase
which included a baseline facility assessment, changes to facility
protocols and charting forms, planning work flow adaptations
to facilitate implementation of the standards, equipment
procurement, training of clinicians, and baseline data collection;
a 12-month implementation phase which included the
implementation of the INTERGROWTH-21st clinical standards,
revised facility protocols and charting forms into routine clinical
practice, and data collection; and a five-month
post-implementation phase which includes analysis and
dissemination.
This study design was based on a conceptual model created by
INTERGROWTH-21st researchers at Oxford University and
researchers at the Harvard T.H. Chan School of Public Health.
Study Setting
This implementation study is currently being carried out at
Jacaranda Health, a social enterprise, 18-bed maternity hospital
that provides women in peri-urban Nairobi with affordable,
safe, and respectful ANC, standard vaginal and cesarean
delivery, and postnatal care (PNC) services. Women in preterm
labor and newborns with LBW and/or complications are not
managed at this facility and are referred to tertiary-level facilities
for specialized care. With a model that emphasizes quality and
affordable care provided primarily by nurse-midwives (and
supported by a team of highly skilled physicians, clinical
educators, and managers), Jacaranda Health provides an ideal
venue for evaluating the implementation of the
INTERGROWTH-21st standards and capturing factors that
facilitate and challenge that process. Jacaranda Health patients
come from densely-populated, peri-urban neighborhoods in
northeastern Nairobi, including Kiambu, Thika, Gatundu, and
Embakasi districts. These areas are served by many facilities
that range from small pharmacies and outpatient care clinics to
private and public sector secondary and tertiary hospitals with
maternity wards; the services and prices vary substantially across
these facilities.
Study Population
Pregnant women with a viable fetus presenting for ANC and/or
delivery at Jacaranda Health were eligible for the following
three elements of the intervention: (1) gestational dating
standards for women who present for their initial ANC visit in
the first or second trimester (more than eight and less than or
equal to 26 weeks gestation); (2) fetal growth monitoring
standards for women who present for an ANC visit in the third
trimester (after 26 weeks gestation) and are identified as
high-risk based on factors related to their surgical, medical, or
obstetric history or current pregnancy; and (3) newborn size at
birth standards for all newborns born at Jacaranda Health. We
excluded pregnant women with a nonviable fetus in both
quantitative and qualitative data collection, women who present
for their initial ANC visit in the third trimester (after 26 weeks
gestation) for gestational dating standards, and parents of
stillborn infants in qualitative data collection. All eligible
pregnant women and mothers of newborns described above
were eligible to participate in FGDs and IDIs.
All clinicians delivering ANC and newborn anthropometry who
attended INTERGROWTH-21st training sessions are eligible
to participate in FGDs, IDIs, and a short clinician survey.
Clinicians who only work in child wellness clinics and not in
prenatal or intrapartum care units were excluded.
Patient and Public Involvement
The development of the study design, research questions, and
outcome measures did not formally involve patient and public
opinions and contributions. However, the study assesses patient
and provider perceptions and experiences of the implementation
of the INTERGROWTH-21st standards at Jacaranda Health to
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assess their acceptability and inform their further scale up. The
results of the study will be disseminated to providers at
Jacaranda Health by study staff at the end of the study.
Preimplementation Phase
Baseline Facility Assessment
Before implementing the INTERGROWTH-21st standards, we
conducted a baseline assessment of current facility practices as
they relate to our study objectives. Focus was placed on policies
and practices related to ANC provision, pregnancy dating,
identification and referral of high-risk pregnancies to high-risk
care within Jacaranda Health and to tertiary facilities, fetal
growth monitoring, newborn size measurement, and indications
for and rates of cesarean section and labor induction.
The baseline assessment was conducted through clinic
observations; a desk review of written policies; IDIs with
Jacaranda Health’s director of clinical operations, clinical
programs manager, and clinical educator; a chart review to
understand clinician practices and indications for and rates of
cesarean sections and labor inductions; an equipment and supply
inventory with a focus on ultrasound and newborn
anthropometry; and a human resource inventory to understand
existing personnel and clinician roles and responsibilities related
to clinic flow, pregnancy dating, fetal growth monitoring, and
patient counseling. We then adapted ANC protocols to align
with the 2002 WHO ANC model [31]. This work was done
prior to the release of the 2016 WHO ANC recommendations
[32].
Protocol, Charting, Equipment, and Work Flow
Adaptations
A key element of preimplementation activities was ensuring
that the hospital’s equipment, protocols, and procedures were
updated and adapted for the implementation of the
INTERGROWTH-21st standards. In partnership with Oxford
University, we created a computerized calculator to calculate
gestational age and fetal growth percentiles: clinicians use the
ultrasound machine to measure the required biometrics for
gestational dating or fetal growth, input the measurements into
the calculator, and then record the resulting gestational age or
fetal growth percentiles in the patient’s chart. Additionally,
neonatal scales, measuring tapes, and infantometers, chosen in
consultation with the INTERGROWTH-21st Oxford team and
adjusted based on local availability and resource constraints,
were sourced and integrated into clinical practice.
We updated Jacaranda Health clinical protocols for standard
ANC, high-risk pregnancy classification and subsequent internal
and tertiary-center referral, gestational dating, fetal growth
monitoring, and newborn anthropometry, in addition to
corresponding patient charting forms, to support the
implementation and evaluation of the INTERGROWTH-21st
standards.
Clinician job aids were created to facilitate the implementation
of the standards and related decision-making algorithms. We
also altered clinic flow processes to accommodate the
introduction of ultrasound services; a separate room was
designated exclusively for gestational dating ultrasounds. In the
context of adapting clinical definitions of high-risk pregnancy
criteria and processes for both internal and tertiary-center
referrals, we trained clinicians to only do activities (like
ultrasound) within their scope of practice as determined by the
Nursing Council of Kenya.
Training
A main aim of implementation was training Jacaranda Health
staff how to use the INTERGROWTH-21st standards. This was
done in collaboration with the original INTERGROWTH-21st
Project study team based at Oxford University and Aga Khan
University Hospital (AKUH) in Nairobi, Kenya [33-37].
From October 2016 to February 2017, we conducted training
of Jacaranda Health clinical and management staff on the
purpose and use of the INTERGROWTH-21st gestational dating
ultrasound, fetal growth monitoring ultrasound, and neonatal
anthropometry standards. Emphasis was placed on including
assessment, identification, and referral of high-risk patients as
part of the study design to evaluate operational system capacity
to support the implementation of the standards and their clinical
implications.
An obstetrician-led half-day training included essential
components of ANC, basic obstetric ultrasound skills, and the
INTERGROWTH-21st standards and accompanying adaptations
to charting practices and clinical protocols. Of the 23
participants in the training, 22 were nurse-midwives and one
was a clinical officer; these staff provide the majority of ANC
and PNC at Jacaranda Health.
An obstetrician and an INTERGROWTH-21st anthropometry
trainer from AKUH provided a half-day anthropometry training
which included theory, equipment, and techniques needed to
perform accurate newborn length, weight, and head
circumference measurements. The anthropometry trainer
certified clinicians in neonatal anthropometry after they
performed length, weight, and head circumference
measurements accurately on newborns. One group of 24
clinicians, 23 nurse-midwives and one clinical officer, attended
this training. Nearly 90% (24/28) of all full-time and part-time
Jacaranda Health clinicians attended these initial trainings.
AKUH trained Jacaranda Health’s primary sonographer in
INTERGROWTH-21st ultrasound measurements for the first,
second, and third trimesters over the course of two weeks. At
the end of the two weeks, the sonographer demonstrated
proficiency in performing INTERGROWTH-21st measurements
as determined by a senior radiologist at AKUH. The Jacaranda
Health sonographer then trained a group of six Jacaranda Health
nurse-midwives with prior experience in basic obstetric
ultrasound during a half-day training on gestational dating
ultrasounds. Three of the six nurse-midwives were certified to
perform gestational dating ultrasounds after proving competence
in performing measurements and calculating estimated delivery
date accurately three consecutive times in the presence of the
sonographer. This group of three nurse-midwives constitutes
over 10% (3/28) of all clinicians.
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Implementation Phase
After training was completed and equipment was put into place,
the INTERGROWTH-21st standards, revised facility protocols,
and adapted patient charting forms were introduced into routine
clinical practice in March 2017. The clinic work flow
adaptations were implemented to facilitate the identification of
pregnant women eligible for ultrasound using the new standards
and ensure that pregnant women were seen by the appropriate
clinician. Work flow adaptations were not needed to implement
the newborn size at birth standards since newborn anthropometry
was an established part of routine practice.
Quality Monitoring
To ensure the quality of the implementation of the
INTERGROWTH-21st standards, three quality monitoring
processes were utilized: expert ultrasound image review, weekly
clinic stakeholder meetings, and targeted refresher training. Our
protocol includes sending copies of de-identified gestational
dating and fetal growth ultrasound images to the quality
assurance team at Oxford University. The team reviews the
images, assesses the quality of each image based on
INTERGROWTH-21st guidelines, and provides guidance to
Jacaranda Health staff on how to improve ultrasound quality,
if needed. Images were sent to Oxford for review every two
months via a double password-protected Dropbox folder. The
program management team at Jacaranda Health then shared
feedback from the Oxford team with the ultrasound providers
to strengthen sonography skills and processes. Reinforcement
training was provided by Oxford University clinical researchers
specializing in sonography midway through implementation to
further improve the quality of the ultrasound procedures.
Challenges in clinical implementation were discussed by the
clinical staff during weekly meetings, which enabled staff to
quickly resolve any problems. Lastly, through chart review and
observation, the clinical and project management teams had the
discretion to identify clinicians who required targeted refresher
training and to provide that training at any point during the
study. Important project notifications and reminders were
administered to all staff at weekly clinical meetings by clinic
managers and project management.
Study outcomes
Primary outcomes
The primary study outcomes are (1) clinicians’ and patients’
perception of facilitators and barriers to the implementation of
the INTERGROWTH-21st standards and (2) uptake of
gestational dating ultrasounds, fetal growth monitoring by
ultrasound, and newborn anthropometry. These outcomes were
explored through the following dimensions: feasibility,
acceptability, appropriateness, adoption, fidelity and penetration
[38].
Secondary outcomes
The secondary outcomes used to evaluate clinical
decision-making include (1) proportion of ANC clients whose
gestational age and estimated due date were correctly calculated
and documented, (2) proportion of high-risk pregnant women
who were referred internally to a high-risk clinician or to a
tertiary care facility, (3) proportion of pregnant women receiving
gestational dating scans who were induced for labor due to a
prolonged pregnancy, and (4) proportion of pregnant women
receiving gestational dating scans who delivered via cesarean
section.
Data collection
During the preimplementation phase, baseline data were
collected for 12 consecutive months (months 1-12) prior to the
start of the implementation phase. Data were also collected for
12 consecutive months during the implementation phase (months
13-24). These preimplementation and implementation phase
quantitative data come from patient charting forms completed
in the two-year period. Qualitative data were also collected
during the preimplementation phase (month eight) and the
implementation phase (month 16 and month 24). Additionally,
a one-time short provider survey was administered during the
implementation phase at month 20 to assess clinicians’ attitudes
and acceptability of the standards. (Table 1).
Quantitative Data Collection
We collected outcome data from patient charts and from a clinic
log of external referrals for pregnancies and deliveries one year
before and one year after the start of implementation.
Table 1. Data collection tools and timeline.
Implementation (months 13-24)Preimplementation (months 1-12)Method and tool
Months 13-24Month 24Month 20Month 16Months 1-12Month 8
Quantitative
XXChart review
XXClinic referral log
Qualitative
XXXPatient in-depth interviews
XXXPatient focus group discussions
XXXClinician in-depth interviews
XXXClinician focus group discussions
XClinician survey
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Qualitative Data Collection
We conducted FGDs and IDIs with participants sampled from
two population groups using purposeful and convenience
sampling: (1) patients who received ANC and/or delivery care
at Jacaranda Health and (2) clinicians who work directly with
patients (providing ANC, delivery care, or anthropometry at
birth) including nurse-midwives, hospital managers,
ultrasonographers, and physicians.
FGDs and IDIs with patients and clinicians were conducted in
the preimplementation phase and twice during the
implementation phase. Patients were interviewed to evaluate
their perceptions, attitudes, and experiences of receiving an
ultrasound for gestational dating and fetal growth, their newborn
receiving a growth assessment, and their interactions with
clinicians implementing this care. Clinicians were interviewed
to evaluate their perceptions, attitudes, and experiences of the
introduction and implementation of the new standards as part
of their routine clinical practice.
The research team developed semistructured discussion guides
for both FGDs and IDIs, which were piloted with Jacaranda
Health staff and patients. Research assistants conducted all
interviews in a private and secure location and took great care
to protect the identity and confidentiality of all participants. To
encourage patient participation in qualitative interviews, we
offered reimbursement for transportation to the facility and free
refreshments after the completion of the interviews. All FGDs
and IDIs were audio-recorded and transcribed verbatim by an
external transcriber; in the instances that participants spoke a
language other than English, the transcriber translated the
recording to English for the transcript. Hand-written notes taken
by the research assistant provided the context for the interviews.
Additionally, a survey (10 questions) was administered by a
research assistant to all clinicians during the implementation
phase at month 20 via Survey Monkey on an Android tablet.
Clinicians were asked to grade their comfort (using a Likert
scale) with the INTERGROWTH-21st standards, the ease of
integration into their workflow, and their perceptions of the
effect of the standards on the quality of care they provided.
Sample Size
We used a census of clinicians and patients for this
implementation study based on the inclusion and exclusion
criteria described prior. According to clinic estimates and
projections of ANC and delivery care utilization, data for up to
5,000 pregnant women and newborns will be recorded. The
total number included in the final analysis will be based on the
number of patients who meet eligibility criteria as confirmed
at the time of data entry based on indicators in patient charting
forms.
In each time period, the sample will be stratified into the
following three categories: (1) pregnant women who attended
ANC at Jacaranda Health and delivered there, allowing analysis
of longitudinal ANC and delivery data; (2) pregnant women
who attended ANC at Jacaranda Health but did not deliver there,
providing ANC data only; and (3) women who did not attend
ANC but who delivered at Jacaranda Health, capturing delivery
and newborn data only. All clinic managers, physicians, and
nurse-midwives who met the criteria are included. Clinician
attrition will be documented.
Postimplementation Phase
Data Analysis and Management
Quantitative Data
Data from patient charts and referral logs were double-entered
and managed in REDCap [39], a secure online data capture
system with built-in data entry restrictions, data quality tools,
and protection of personally identifiable information. Quality
control measures have been in place to check the data at various
stages on a routine basis using REDCap [39] and Stata 15 [40].
REDCap’s data quality features were utilized to ensure that data
was entered within acceptable ranges and in the proper formats
[39]. Additionally, data were checked for consistency and errors
using a Stata 15 [40] script. All discrepancies have been resolved
by checking original paper charts.
Most implementation and process indicators will be measured
and presented using descriptive statistics. We will analyze
changes in quantitative outcomes where relevant, by evaluating
the difference in response to the indicators between pre- and
postimplementation. Measurements of differences in continuous
data will be assessed using t-tests for data that is normally
distributed; otherwise, a non-parametric test will be performed.
Categorical data will be compared using a chi-squared test.
Quantitative data will be analyzed using Stata 15 [40]. All data
will be de-identified before analysis begins.
Qualitative Data
For each cycle of qualitative data transcription, the transcriber
completed transcription of one initial data file and sent it to the
qualitative data manager at Jacaranda Health for quality control
prior to transcribing the rest of the data files.
Qualitative data collected at each stage are being analyzed
independently by two investigators using thematic coding in
NVivo [41] and compared across time. Transcribed,
de-identified qualitative data are being stored in a double
password-protected Dropbox folder accessible only to a select
number of study personnel.
Dissemination Policy
Results of the study will be shared with key stakeholders both
in Kenya and globally through a national dissemination meeting,
global conferences, an online knowledge management platform,
and publications.
Ethical Considerations
The Amref Ethics and Scientific Review Committee of Kenya
and the Harvard University Institutional Review Board approved
all study activities, protocols, and standards prior to the
commencement of study activities.
Facility-level informed consent was obtained from the Jacaranda
Health hospital manager, acting as the facility’s representative,
prior to the collection of any implementation data. The facility
informed consent emphasized that no patient-identifiable health
data would be shared or disseminated beyond the Jacaranda
Health team. All FGD, IDI, and survey participants—patients
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and clinicians—provided written informed consent prior to any
interview. Participants were informed that they could withdraw
their consent at any time and be removed from the sample.
Results
From October 2016 to February 2017, over 90% of all Jacaranda
Health clinicians (25 nurse-midwives and one clinical officer
of 28 total Jacaranda Health clinicians) received at least one of
the three aspects of the INTERGROWTH-21st training:
gestational dating ultrasound, fetal growth monitoring
ultrasound, and neonatal anthropometry standards. Following
the training, the implementation and study of the
INTERGROWTH-21st standards as part of Jacaranda’s clinical
workflow took place from March 2017 through March 5, 2018.
Data analysis will be finalized, and results are expected in
August 2018.
Discussion
Significance
The findings of this study will have major implications on the
national and global scale up of the INTERGROWTH-21st
standards and on the process of scaling up global standards in
general, particularly in limited-resource settings. The ability to
implement a standard methodology of gestational dating, fetal
growth monitoring, and assessment of newborn size at birth
will result in better data to enable clinicians, researchers, and
policy makers to more accurately identify and quantify high-risk
pregnancies, preterm birth, and fetal and neonatal growth
disturbances. In turn, standardized data that is comparable across
global populations empowers researchers and policy makers to
better understand and act on distributions of high-risk
pregnancies, restricted growth, and prematurity. Lastly, based
on this data, clinical practice and resources can be modified to
meet the needs of pregnant women and their fetuses and
newborns to decrease the incidence and morbidities associated
with poor fetal and newborn growth and prematurity.
Limitations
While Jacaranda Health provides the right environment for this
study, the generalizability of our findings needs to be carefully
considered when applying lessons learned to other clinical
settings. Given that clinic protocols were amended to meet the
2002 WHO ANC guidelines, which affected the criteria for
high-risk referral, this change may confound the outcome of
the percentage of women who are referred to high-risk care.
The study is also limited in its ability to assess the long-term
health outcomes of these standards, yet it will inform future
research designed to assess them.
Strengths
This will be the first study to assess the feasibility and
acceptability of introducing the new INTERGROWTH-21st
clinical standards into a low-resource setting. Due to the dearth
of innovative gestational dating tools and burden of preterm
birth in low-resource settings, it is particularly important to
study the implementation of these standards in this setting. The
results of our evaluation will provide useful insights and
recommendations for further implementation in similar clinical
settings in Kenya and beyond.
Additionally, the mixed-methods approach used in this study
will yield unique insights into the barriers, facilitators, and
process of implementing the INTERGROWTH-21st standards
and the resulting impact on short-term clinical decision-making.
Lastly, Jacaranda Health is dedicated to health facility quality
improvement in peri-urban Nairobi, which makes it an excellent
venue for evaluating the implementation of the
INTERGROWTH-21st standards and for capturing factors that
facilitate and challenge that process.
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